Show Notes
Podcast Host and Interviewee: Dr. Haseeb Mehmood Qadri interviews Prof. Dr. Ghazaleh Tabatabai
Dr. Haseeb Mehmood Qadri interviews Prof. Dr. Ghazaleh Tabatabai from the Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Germany on their manuscript, entitled Clinical outcome of biomarker-guided therapies in adult neuro-oncology patients: An update from the Tübingen molecular tumor board cohort
More from Neuro-Oncology: The Podcast
Dr. Evan Noch interviews Dr. Nathan Dalton on his journey founding the charity Baking for Brain Cancer to support brain tumor research in Australia.
Dr. Daniel Zamler interviews Dr. Sriram Venneti on recent advances in Ependymoma research. Topics include subtyping, targeted therapies, and what is currently needed in the field. Podcast Host and Interviewee: Host: Dr. Daniel Zamler Interviewee: Dr. Sriram Venneti
What if a tumor's hidden dependence on Ras could become its biggest vulnerability? In this episode, Dr. Stephanie Grace Spurgeon and Dr. Cynthia Hawkins explain how their team engineered a targeted biologic to shut down Ras signaling in diffuse midline glioma—and what their preclinical findings reveal about reaching these aggressive tumors, including disease that spreads beyond the brainstem. Could this approach open a new path toward treatment? Listen to find out.
Dr. Matthew Sun interviews Dr. Ramona-Alexandra Todea and Dr. Riccardo Ludovichetti at University hospital Zurich about their paper recently published in Neuro-oncology advances, titled "Prediction of treatment failure in patients with glioblastoma with perfusion MRI and molecular biomarkers" Podcast Host and Interviewee: Host: Dr. Matthew Sun Interviewees: Dr. Ramona-Alexandra Todea and Dr. Riccardo Ludovichetti
Live from EANO, Dr. Evan Noch interviews EANO President Dr. Michael Platten and EANO President-Elect Dr. Roberta Rudà